Zai Lab (ZLAB) EBITDA Margin (2020 - 2025)
Zai Lab (ZLAB) has disclosed EBITDA Margin for 6 consecutive years, with 55.69% as the latest value for Q4 2025.
- Quarterly EBITDA Margin rose 687.0% to 55.69% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 94.63% through Dec 2025, up 3896.0% year-over-year, with the annual reading at 50.18% for FY2025, 2077.0% up from the prior year.
- EBITDA Margin hit 55.69% in Q4 2025 for Zai Lab, down from 42.05% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 65.62% in Q4 2022 to a low of 105891.79% in Q4 2021.
- Historically, EBITDA Margin has averaged 10277.77% across 5 years, with a median of 193.04% in 2021.
- Biggest five-year swings in EBITDA Margin: crashed -10526070bps in 2021 and later soared 10595741bps in 2022.
- Year by year, EBITDA Margin stood at 105891.79% in 2021, then surged by 100bps to 65.62% in 2022, then crashed by -171bps to 46.48% in 2023, then tumbled by -35bps to 62.57% in 2024, then increased by 11bps to 55.69% in 2025.
- Business Quant data shows EBITDA Margin for ZLAB at 55.69% in Q4 2025, 42.05% in Q3 2025, and 6154.15% in Q2 2025.